All In MedTech

FDA Clearance Tracker · P010018-S006

VIEWPOINT CK SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 15, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 15, 2004

Approved

Time to decision

42 days

Received Dec 4, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010018-S006
Device name
VIEWPOINT CK SYSTEM
Applicant location
Irvine, CA
Received
Dec 4, 2003
Decided
Jan 15, 2004
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010018

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MWD

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN ALTERNATE MANUFACTURING SITE FOR THE SUB-ASSEMBLY OF THE RCS-300 CONSOLE COMPONENT AT STELLARTECH RESEARCH CORP., SUNNYVALE, CALIFORNIA.

Source documents

Other decisions for Refractec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.